{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:47:34Z","timestamp":1761155254062,"version":"3.37.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00066-009-1937-4","type":"journal-article","created":{"date-parts":[[2009,5,13]],"date-time":"2009-05-13T23:34:40Z","timestamp":1242257680000},"page":"288-295","source":"Crossref","is-referenced-by-count":25,"title":["Long-Term Outcome and Prognostic Factors in Early-Stage Nodal Low-Grade Non-Hodgkin\u2019s Lymphomas Treated with Radiation Therapy","Behandlungsergebnisse und prognostische Faktoren nach Radiotherapie niedrigmaligner nodaler Non-Hodgkin-Lymphome in fr\u00fchen Stadien"],"prefix":"10.1007","volume":"185","author":[{"given":"Hans Theodor","family":"Eich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hartmut","family":"St\u00fctzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Kriz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf-Peter","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,15]]},"reference":[{"key":"1937_CR1","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/1097-0142(19950501)75:9<2361::AID-CNCR2820750928>3.0.CO;2-N","volume":"75","author":"P.C. Besa","year":"1995","unstructured":"Besa PC, McLaughlin PW, Cox JD, et al. Long term assessment of patterns of treatment failure and survival in patients with stage I or II follicular lymphoma. Cancer 1995;75:2361\u20137.","journal-title":"Cancer"},{"key":"1937_CR2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00066-007-1627-z","volume":"183","author":"M. Bischof","year":"2007","unstructured":"Bischof M, Karagiozidis M, Krempien R, et al. Radiotherapy for orbital lymphoma. Outcome and late effects. Strahlenther Onkol 2007; 183:17\u201322.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR3","first-page":"1860","volume":"31","author":"P.P. Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin\u2019s Disease staging classification. Cancer Res 1971;31:1860\u20131.","journal-title":"Cancer Res"},{"key":"1937_CR4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00761-006-1059-x","volume":"12","author":"B. Chapuy","year":"2006","unstructured":"Chapuy B, Borchmann P, Engert A, et al. Targeted-Therapie. Neue Zielstrukturen und Substanzen in der Behandlung maligner Lymphome. Onkologe 2006;12:651\u20138.","journal-title":"Onkologe"},{"key":"1937_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"B34","author":"D.R. Cox","year":"1972","unstructured":"Cox DR. Regression models and life tables (with discussion). J R Stat Soc 1972;B34:187\u2013202.","journal-title":"J R Stat Soc"},{"key":"1937_CR6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0959-8049(95)00607-9","volume":"32A","author":"J.W. Denham","year":"1996","unstructured":"Denham JW, Denham E, Dear KB, et al. The follicular non-Hodgkin\u2019s lymphomas \u2014 I. The possibility of cure. Eur J Cancer 1996;32A:470\u20139.","journal-title":"Eur J Cancer"},{"key":"1937_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s00761-006-1060-4","volume":"12","author":"M. Dreyling","year":"2006","unstructured":"Dreyling M, Schmidberger H, Hiddemann W. Aktuelle Therapieoptionen des indolenten Lymphoms. Onkologe 2006;12:612\u20138.","journal-title":"Onkologe"},{"key":"1937_CR8","first-page":"129","volume":"183","author":"M. Engelhard","year":"2007","unstructured":"Engelhard M, Allg\u00e4uer M, Amela-Neuschwander S, et al. Follicular lymphoma, immunocytoma, and mantle cell lymphoma: randomized evaluation of curative radiotherapy in limited stage nodal disease. Strahlenther Onkol 2007;183:Special Issue 1:129.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR9","first-page":"17","volume":"182","author":"M. Engelhard","year":"2006","unstructured":"Engelhard M, Allg\u00e4uer M, Bamberg M, et al. Follicular lymphoma, immunocytoma, and mantle cell lymphoma: prospective evaluation of curative radiotherapy in limited stage nodal disease. Strahlenther Onkol 2006;182: Special Issue 1:17.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR10","first-page":"1052","volume-title":"Radioonkologie 2","author":"M. Engelhard","year":"2004","unstructured":"Engelhard M, Stuschke M. Non-Hodgkin-Lymphome. In: Bamberg M, Molls M, Sack H, Hrsg. Radioonkologie 2. Klinik. M\u00fcnchen-Wien-NewYork: Zuckschwerdt, 2004:1052\u201397."},{"key":"1937_CR11","first-page":"66","volume":"162","author":"R. Epelbaum","year":"1992","unstructured":"Epelbaum R, Kuten A, Coachman NM, et al. Stage I-II low grade non-Hodgkin\u2019s lymphoma: prognostic factors and treatment results. Strahlenther Onkol 1992;162:66\u201372.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR12","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/PL00002370","volume":"177","author":"C. Frank","year":"2001","unstructured":"Frank C, Zierhut D, Schulz-Ertner D, et al. Centroblastic-centrocytic non-Hodgkin\u2019s lymphoma stage I\u2013III: patterns of failure following radiotherapy. Strahlenther Onkol 2001;177:597\u2013603.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","volume":"64","author":"B.A. Guadagnolo","year":"2006","unstructured":"Guadagnolo BA, Li S, Neuberg D, et al. Long-term outcome and mortality trends in early-stage, grade 1-2 follicular lymphoma treated with radiation therapy. Int J Radiat Oncol Biol Phys 2006;64:928\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1937_CR14","first-page":"17","volume":"182","author":"A. Haidenberger","year":"2006","unstructured":"Haidenberger A, Popper BA, Ginestet A, et al. Kombinierte Radio\/Immuntherapie mit MabThera (Rituximab) bei Non-Hodgkin-Lymphomen \u2014 Pilotstudie. Strahlenther Onkol 2006;182:Sondernr 1:17.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR15","first-page":"130","volume":"183","author":"F. Heinzelmann","year":"2007","unstructured":"Heinzelmann F, Lang PJ, Ottinger H, et al. TLI (total lymphoid irradiation\/total lymphatische Bestrahlung) basierte Rekonditionierung erm\u00f6glicht engraftment und Langzeit\u00fcberleben nach Transplantatversagen bei Patienten mit h\u00e4matologischen Systemerkrankungen. Strahlenther Onkol 2007;183: Sondernr 1:130.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0360-3016(99)00051-6","volume":"44","author":"S.S. Kamath","year":"1999","unstructured":"Kamath SS, Marcus RB, Lynch JW, et al. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin\u2019s lymphoma. Int J Radiat Oncol Biol Phys 1999;44: 563\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1937_CR17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"E.L. Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimations from incomplete observations. J Am Stat Assoc 1958;53:457\u201381.","journal-title":"J Am Stat Assoc"},{"key":"1937_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02990087","volume":"11","author":"S.M. Kelsey","year":"1994","unstructured":"Kelsey SM, Newland AC, Vaughan Hudson G, et al. A British National Lymphoma Investigation randomized trial of single agent chlorambucil plus radiotherapy versus radiotherapy alone in low grade, localised non-Hodgkin\u2019s lymphoma. Med Oncol 1994;11:19\u201325.","journal-title":"Med Oncol"},{"key":"1937_CR19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0360-3016(88)90254-4","volume":"14","author":"T.S. Lawrence","year":"1988","unstructured":"Lawrence TS, Urba WJ, Steinberg SM, et al. Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute. Int J Radiat Oncol Biol Phys 1988;14:417\u201324.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1937_CR20","unstructured":"Leitch HA, Gascoyne RD, Chhanabhai M, et al. Limited stage mantle cell lymphoma: clinical outcome in patients from British Columbia. Blood 2001;98:342a.abstract 1443."},{"key":"1937_CR21","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","volume":"14","author":"M.P. MacManus","year":"1996","unstructured":"MacManus MP, Hoppe RT. Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University. J Clin Oncol 1996;14:1282\u201390.","journal-title":"J Clin Oncol"},{"key":"1937_CR22","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/PL00022793","volume":"80","author":"P. Mauch","year":"2001","unstructured":"Mauch P. Follicular non-Hodgkin\u2019s lymphoma: the role of radiation therapie. Ann Hematol 2001;80:6\u201365.","journal-title":"Ann Hematol"},{"key":"1937_CR23","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1002\/1097-0142(19861015)58:8<1596::AID-CNCR2820580803>3.0.CO;2-G","volume":"58","author":"P. McLaughlin","year":"1986","unstructured":"McLaughlin P, Fuller LM, Velasquez WS, et al. Stage I-II follicular lymphoma. Cancer 1986;58:1596\u2013602.","journal-title":"Cancer"},{"key":"1937_CR24","unstructured":"MIR-Studie (MabThera und Involved-field Radiotherapie). Therapie des nodalen follikul\u00e4ren Non-Hodgkin-Lymphoms (WHO Grad I\/II) im klinischen Stadium I\/II mittels involved-field Bestrahlung in Kombination mit Rituximab. ARO 2007-2."},{"key":"1937_CR25","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0360-3016(80)90027-9","volume":"6","author":"S. Monfardini","year":"1980","unstructured":"Monfardini S, Banfi A, Bonadonna G, et al. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin\u2019s lymphoma. Int J Radiat Oncol Biol Phys 1980;6:125\u201334.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1937_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0360-3016(00)00780-X","volume":"49","author":"A.D. Murtha","year":"2001","unstructured":"Murtha AD, Knox SJ, Hoppe RT, et al. Long-term follow-up of patients with stage III follicular lymphoma treated with primary radiotherapy at Stanford University. Int J Radiat Oncol Biol Phys 2001;49:3\u201315.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1937_CR27","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1007\/s00066-003-1025-0","volume":"179","author":"H. Neumann","year":"2003","unstructured":"Neumann H, Blanck H, Koch R, et al. Behandlungsergebnisse beim follikul\u00e4ren Keimzentrumslymphom Stadium I und II. Strahlenther Onkol 2003;179:840\u20136.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00066-007-1657-6","volume":"183","author":"M. Nevinny-Stickel","year":"2007","unstructured":"Nevinny-Stickel M, Poljanc K, Forthuber BC, et al. Optimized conformal paraaortic lymph node irradiation is not associated with enhanced renal toxicity. Strahlenther Onkol 2007;183:385\u201391.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR29","first-page":"97","volume-title":"Manual Maligne Lymphome","author":"C. Nickening","year":"2004","unstructured":"Nickening C, Dreyling M, Nerl C, et al. Follikul\u00e4re und andere indolente Lymphome. Manual Maligne Lymphome. M\u00fcnchen: Tumorzentrum, Zuckschwerdt, 2004:97\u2013107."},{"key":"1937_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-0142(19830701)52:1<1::AID-CNCR2820520102>3.0.CO;2-M","volume":"52","author":"N.N. Nissen","year":"1983","unstructured":"Nissen NN, Ersboll J, Hansen HS, et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I\u2013II non-Hodgkin\u2019s lymphomas. Cancer 1983;52:1\u20137.","journal-title":"Cancer"},{"key":"1937_CR31","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s00066-003-1062-8","volume":"179","author":"O.J. Ott","year":"2003","unstructured":"Ott OJ, R\u00f6del C, Gramatzki M, et al. Radiotherapy for stage I\u2013III nodal low grade non-Hodgkin\u2019s lymphoma. Strahlenther Onkol 2003;179:694\u2013701.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR32","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/1097-0142(19831215)52:12<2300::AID-CNCR2820521224>3.0.CO;2-Y","volume":"52","author":"S.B. Paryani","year":"1983","unstructured":"Paryani SB, Hoppe RT, Cox RS, et al. Analysis of non-Hodgkin\u2019s lymphomas with nodular and favorable histologies, stages I and II. Cancer 1983;52:2300\u20137.","journal-title":"Cancer"},{"key":"1937_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-8140(95)01600-L","volume":"36","author":"S. Pendlebury","year":"1995","unstructured":"Pendlebury S, El Awadi M, Ashley S, et al. Radiotherapy results in early stage low grade nodal non-Hodgkin\u2019s lymphoma. Radiother Oncol 1995;36:167\u201371.","journal-title":"Radiother Oncol"},{"key":"1937_CR34","doi-asserted-by":"crossref","unstructured":"Petersen PM, Gospodarowicz M, Tsang R, et al. Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone. J Clin Oncol 2004;22:Suppl:563s.abstract.","DOI":"10.1200\/jco.2004.22.14_suppl.6521"},{"key":"1937_CR35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00066-007-1697-y","volume":"183","author":"J. Roth","year":"2007","unstructured":"Roth J, Martinez AE. Determination of organ doses and effective doses in radiooncology. Strahlenther Onkol 2007;183:392\u20137.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR36","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/BF03038523","volume":"174","author":"H. Sack","year":"1998","unstructured":"Sack H, Hoederath A, Stuschke M, et al. Strahlenbehandlung von follikul\u00e4ren Keimzentrumslymphomen. Ergebnisse einer deutschen multizentrischen und prospektiven Studie. Strahlenther Onkol 1998;174:178\u201385.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00066-007-1656-7","volume":"183","author":"R.A. Schneider","year":"2007","unstructured":"Schneider RA, Schultze J, Jensen JM, et al. 20 years of experience in static intensity-modulated total-body irradiation and lung toxicity. Results in 257 consecutive patients. Strahlenther Onkol 2007;183:545\u201351.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00066-006-1534-8","volume":"182","author":"U. Schneider","year":"2006","unstructured":"Schneider U, Lomax A, Pemler P, et al. The impact of IMRT and proton radiotherapy on secondary cancer incidence. Strahlenther Onkol 2006;182: 647\u201352.","journal-title":"Strahlenther Onkol"},{"key":"1937_CR39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0167-8140(88)90030-8","volume":"13","author":"P. Soubeyran","year":"1988","unstructured":"Soubeyran P, Eghbali H, Bonichon F, et al. Localized follicular lymphomas: prognosis and survival of stages I and II in a retrospective series of 103 patients. Radiother Oncol 1988;13:91\u20138.","journal-title":"Radiother Oncol"},{"key":"1937_CR40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0009-9260(88)80537-3","volume":"39","author":"R.E. Taylor","year":"1988","unstructured":"Taylor RE, Allan SG, McIntyre MA, et al. Low grade stage I and II non-Hodgkin\u2019s lymphoma: results of treatment and relapse pattern following therapy. Clin Radiol 1988;39:287\u201390.","journal-title":"Clin Radiol"},{"key":"1937_CR41","unstructured":"Therapie der niedrigmalignen nodalen Non-Hodgkin Lymphome in fr\u00fchen Stadien mit alleiniger Radiotherapie, ARO Reg. Nr. 1\/98 Deutsche Krebshilfe 70-2317-Sa 13, 2. Aufl."},{"key":"1937_CR42","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/bjc.1994.213","volume":"69","author":"B. Vaughan Hudson","year":"1994","unstructured":"Vaughan Hudson B, Vaughan Hudson G, Maclennan KA, et al. Clinical stage I non-Hodgkin\u2019s lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy. Br J Cancer 1994; 69:1088\u201393.","journal-title":"Br J Cancer"},{"key":"1937_CR43","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/1097-0142(19930401)71:7<2342::AID-CNCR2820710728>3.0.CO;2-I","volume":"71","author":"J. Yahalom","year":"1993","unstructured":"Yahalom J, Varsos G, Fuks Z, et al. Adjuvant cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy after radiation therapy in stage I low-grade and intermediate-grade non-Hodgkin lymphoma. Cancer 1993;71:2342\u201350.","journal-title":"Cancer"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-1937-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-009-1937-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-009-1937-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T11:40:11Z","timestamp":1739101211000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-009-1937-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["1937"],"URL":"https:\/\/doi.org\/10.1007\/s00066-009-1937-4","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"type":"print","value":"0179-7158"},{"type":"electronic","value":"1439-099X"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}